Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Shares of Gilead Sciences Inc. GILD rose 1.04% to $98.90 Wednesday, on what proved to be an all-around great trading session ...

Shares of Gilead Sciences Inc. GILD slid 4.80% to $97.88 Tuesday, on what proved to be an all-around poor trading session for ...

Gilead (GILD) stock and Vertex Pharma (VRTX) stock are said to be relatively immune to Trump administration's tariffs threats ...

Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump ...

Gilead Sciences (NASDAQ:GILD) announced an additional $11B in capital and operational investments in the U.S. on Wednesday. The $11B investment adds onto an already planned spend of $21B in U.S.

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences said Wednesday it will invest $11 billion in U.S. research and manufacturing in the coming years, joining other drugmakers that have promised to bolster domestic capabilities as they ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

Gilead Sciences (NASDAQ:GILD), a leading biopharmaceutical company, has today outlined plans to create $43 billion in value for the U.S. economy over the next five years through direct capital ...